The type of plasticizer and the choice of solvent or co-solvents used for coating of a hydrophilic core can greatly impact the permeability, porosity, and mechanical strength of the polymer film. Although, Ethylcellulose (EC) is an old polymer, it is a polymer of choice for modifying the drug release due to its inherent properties. The ability of polymers like EC alone to form a diffusion-controlling membrane with good mechanical properties is limited. To modulate the drug release as per the desired profile and modify the film properties, ethylcellulose is often used with hydrophilic hypromellose (HPMC) along with plasticizers. The main focus of the current study was the identification of an appropriate solvent system and plasticizer for the ethylcellulose-hypromellose polymer combination. The study evaluated the coating solution properties, the feasibility and efficiency of the process, the physical attributes of the tablet, the surface properties of the polymer film, the in-vitro drug release and behavior, and the impact of curing time on surface properties and drug release, among other factors. The isopropyl alcohol-water mixture (9:1) produced a homogeneous film in comparison to films produced by other solvents. Although both hydrophilic and hydrophobic plasticizers produce homogeneous films, hydrophilic plasticizers have a higher rate of drug diffusion than hydrophobic plasticizers. During the tablet curing and stability study, the drug release from the polymeric film coating with triethyl citrate decreased moderately and with polyethylene glycol decreased significantly. The presence of hydrophobic plasticizers, viz., dibutyl sebacate and acetyl tributyl citrate, in the polymeric film coating does not impact drug release. For the combination of ethylcellulose and hypromellose, it was found that a mixture of isopropyl alcohol and water (9:1) worked better as a solvent for coating solutions, and hydrophobic plasticizers lower the risk associated with coating ethylcellulose and hypromellose together.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481617 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2024.e37938 | DOI Listing |
Expert Opin Drug Deliv
January 2025
Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Moscow, Russia.
Introduction: The pursuit of linear dosage in pharmacy is essential for achieving consistent therapeutic release and enhancing patient compliance. This review provides a comprehensive summary of zero-order drug delivery systems, with a particular focus on reservoir-based systems emanated from different microfabrication technologies.
Areas Covered: The consideration of recent advances in drug delivery systems is given to encompass the key areas including the importance of achieving a constant drug release rate for therapeutic applications.
Pharm Dev Technol
January 2025
Department of Pharmacy, School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China.
In this paper, the pH-sensitive targeting functional material NGR-poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate (NGR-PEtOz-CHMC, NPC) modified quercetin (QUE) liposomes (NPC-QUE-L) was constructed. The structure of NPC was confirmed by infrared spectroscopy (IR) and nuclear magnetic resonance hydrogen spectrum (H-NMR). Pharmacokinetic results showed that the accumulation of QUE in plasma of the NPC-QUE-L group was 1.
View Article and Find Full Text PDFBeilstein J Nanotechnol
December 2024
Department of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung (ITB), Bandung 40132, Indonesia.
Endosomal entrapment significantly limits the efficacy of drug delivery systems. This study investigates sodium oleate-modified liposomes (SO-Lipo) as an innovative strategy to enhance endosomal escape and improve cytosolic delivery in 4T1 triple-negative breast cancer cells. We aimed to elucidate the mechanistic role of sodium oleate in promoting endosomal escape and compared the performance of SO-Lipo with unmodified liposomes (Unmodified-Lipo) and Aurein 1.
View Article and Find Full Text PDFLiposomal doxorubicin (Dox), a treatment option for recurrent ovarian cancer, often suffers from suboptimal biodistribution and efficacy, which might be addressed with precision drug delivery systems. Here, we introduce a catheter-based endoscopic probe designed for multispectral, quantitative monitoring of light-triggered drug release. This tool utilizes red-light photosensitive porphyrin-phospholipid (PoP), which is encapsulated in liposome bilayers to enhance targeted drug delivery.
View Article and Find Full Text PDFHIV Res Clin Pract
December 2025
National Heart and Lung Institute, Imperial College London, London, UK.
Introduction: The BIC-T&T study aimed to determine the efficacy of bictegraviremtricitabine/tenofovir alafenamide (BIC/F/TAF) and darunavir/cobicistat/emtricitabinetenofovir alafenamide (DRV/c/F/TAF) at suppressing viral load in a two-arm, open-label, multi-centre, randomised trial under a UK test-and-treat setting. This sub-study aimed to evaluate potential off-target cardiovascular impact by examining platelet function.
Methods: Platelets were isolated by centrifugation of citrated blood from participants attending Chelsea and Westminster Hospital or St Mary's Hospital at Week 48 following enrolment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!